The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to sacituzumab govitecan-hziy (Trodelvy®) for extensive-stage small cell lung cancer.
The research could supplement patient-reported symptoms upon hospital admission for transplant procedures to predict which patients could benefit from receiving palliative care.
The FDA rejected a new drug application for sotagliflozin (Zynquista) for use as an add-on to insulin therapy for glycemic control in adults with type…
The randomized phase 3 study is evaluating amivantamab-vmjw (RYBREVANT®) plus lazertinib (LAZCLUZE™) versus osimertinib as a first-line treatment for non-small cell lung cancer.
Even temporary shift to more plant-based foods can help boost gut health
Even temporary shift to more plant-based foods can help boost gut health
AbstractBackgroundPatients with repaired tetralogy of Fallot (rTOF) have a time-dependent increased risk of ventricular tachycardia (VT). Slow conducting anatomical isthmuses (SCAIs) are the domina…
A study documented findings on vitamin D and metabolic bone disease in children requiring prolonged continuous kidney replacement therapy (CKRT).
Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment. To aid in achieving this objective, a three-part Expert…
Wajeeha Aiman, MD, and Muhammad Ashar Ali, MD, discuss the benefits of attending the SOHO Annual Meeting in Houston, Texas, for early-career healthcare professionals. Drs.…
